Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Anvarbatcha Riyasdeen"'
Autor:
Islam, Mozaffarul1 (AUTHOR), Anvarbatcha, Riyasdeen1 (AUTHOR), Kunnathodi, Faisal1 (AUTHOR), Athar, Md2 (AUTHOR), Tariq, Mohammad1 (AUTHOR)
Publikováno v:
Journal of Cancer Research & Therapeutics. Oct-Dec2023, Vol. 19 Issue 7, p1988-1997. 10p.
Publikováno v:
Journal of Cancer Research & Therapeutics. Oct-Dec2023, Vol. 19 Issue 7, p1915-1924. 10p.
Autor:
Vaiyapuri Subbarayan Periasamy, Anvarbatcha Riyasdeen, Venugopal Rajendiran, Mallayan Palaniandavar, Hanumanthappa Krishnamurthy, Ali Abdullah Alshatwi, Mohammad Abdulkader Akbarsha
Publikováno v:
Molecules, Vol 25, Iss 19, p 4504 (2020)
This research was aimed at finding the cytotoxic potential of the mixed ligand copper(II) complex [Cu(tdp)(phen)](ClO4)—where H(tdp) is the tetradentate ligand 2-[(2-(2-hydroxyethylamino)-ethylimino)methyl]phenol, and phen is 1,10-phenanthroline—
Externí odkaz:
https://doaj.org/article/feb8b26d54e9447abf5374d637e3becb
Publikováno v:
Integrative Cancer Therapies, Vol 17 (2018)
Scorpion venoms efficiently block the normal neurotransmitter signaling pathway by prejudicing the ion channel operating mechanism in the body system. Besides its negative effect, venoms also possess some beneficial qualities for humans. They have al
Externí odkaz:
https://doaj.org/article/81e267f9d4004c8a968fedd494a416e7
Publikováno v:
Journal of Evidence-Based Integrative Medicine, Vol 23 (2018)
Objectives. The objective of this study was to examine the effect of scorpion venoms on cancer cell progression, apoptosis, and cell cycle arrest. Scorpion venoms are known to possess numerous bioactive compounds that act against cancer progression b
Externí odkaz:
https://doaj.org/article/4d452496fcd646c2a9e88ddfcbd4d2e2
Publikováno v:
Integrative Cancer Therapies
Scorpion venoms efficiently block the normal neurotransmitter signaling pathway by prejudicing the ion channel operating mechanism in the body system. Besides its negative effect, venoms also possess some beneficial qualities for humans. They have al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6831a00b3fbd2e98002737caba997c3f
http://europepmc.org/articles/PMC6041906
http://europepmc.org/articles/PMC6041906
Autor:
Rajendran Senthilkumar, Hanumanthappa Krishnamurthy, Suresh Srinag, Vaiyapuri Subbarayan Periasamy, Anvarbatcha Riyasdeen, Mohammed Zeeshan, Sankaralingam Arunachalam, Mohammad Abdulkader Akbarsha, Paul Preethy
Publikováno v:
RSC Adv.. 4:49953-49959
The cytotoxic potential of the surfactant–cobalt(III) complex (metallosurfactant) cis-[Co(trien)(C14H29NH2)Cl](ClO4)2 was tested on the MCF-7 breast cancer cell. The viability of the treated cell was evaluated by adopting MTT assay. The mode of cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12150aa71a60b2f3ef21133f64fe034e
https://doi.org/10.1039/c4ra06702a
https://doi.org/10.1039/c4ra06702a
Autor:
Sethu Ramakrishnan, Mani Ganeshpandian, Mallayan Palaniandavar, Rangasamy Loganathan, Mohamad Abdulkadhar Akbarsha, Anvarbatcha Riyasdeen
Publikováno v:
Polyhedron. 52:924-938
A series of mononuclear mixed ligand copper(II) complexes of the type [Cu(pmdt)(diimine)](ClO4)2 1–4, where pmdt is N,N,N′,N″,N″-pentamethyldiethylenetriamine and diimine is 2,2′-bipyridine (1), 1,10-phenanthroline (2), 5,6-dimethyl-1,10-ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a401777587fa3133c9f067a6a46a294
https://doi.org/10.1016/j.poly.2012.07.021
https://doi.org/10.1016/j.poly.2012.07.021
Autor:
Mani Ganeshpandian, Anvarbatcha Riyasdeen, Amsaveni Muruganantham, Rangasamy Loganathan, Mohammad Abdulkader Akbarsha, Swapan K. Ghosh, Mallayan Palaniandavar, Nattamai Bhuvanesh
Publikováno v:
Journal of inorganic biochemistry. 174
The water soluble mixed ligand complexes [Cu(nal)(diimine)(H2O)](ClO4) 1-4, where H(nal) is nalidixic acid and diimine is 2,2'-bipyridine (1), 1,10-phenanthroline (2), 5,6-dimethyl-1,10-phenanthroline (3), and 3,4,7,8-tetramethyl-1,10-phenanthroline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7390dd57dc26df4540f4e862e4b99a7e
https://pubmed.ncbi.nlm.nih.gov/28551479
https://pubmed.ncbi.nlm.nih.gov/28551479
Autor:
Mohammad Hamed Al-Shahrani, Abdulrahman K. Al-Asmari, Anvarbatcha Riyasdeen, Mozaffarul Islam
Publikováno v:
OncoTargets and therapy
Abdulrahman Khazim Al-Asmari,1 Anvarbatcha Riyasdeen,1 Mohammad Hamed Al-Shahrani,2 Mozaffarul Islam1 1Research Center, 2Pediatric Hematology/Oncology and Bone Marrow Transplant Unit, Prince Sultan Military Medical City, Riyadh, Kingdom of Saudi Arab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0239295ac46887fab438e9b961c97b79
https://pubmed.ncbi.nlm.nih.gov/36303950
https://pubmed.ncbi.nlm.nih.gov/36303950